Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06554119

Surgical Treatments of Tricuspid Valve Regurgitation After Cardiac Surgery

This study aims to present our center's experience in managing postoperative tricuspid valve regurgitation over the past 25years and to analyze the outcomes of these surgical treatments.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Tricuspid Valve Regurgitation; Complications, Longterm Outcome Cardiovascular Diseases Heart Diseases Heart Valve Diseases Tricuspid Valve Insufficiency

Age range

16 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University

Guangzhou, Guangdong, 510080, China

Location status: Recruiting

Location contact

Huanlei Huang

CONTACT

[email protected]

02083827812

Huanlei Huang

PRINCIPAL_INVESTIGATOR

Junfei Zhao

SUB_INVESTIGATOR

Linbin Hua

SUB_INVESTIGATOR

Lishan Zhong

SUB_INVESTIGATOR

Qiuji Wang

SUB_INVESTIGATOR

Shanwen Pang

SUB_INVESTIGATOR

Shuo Xiao

SUB_INVESTIGATOR

Yingjie Ke

SUB_INVESTIGATOR

Zhaolong Zhang

SUB_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients who underwent surgical treatment from 1999 to 2023 for tricuspid valve disease following cardiac surgery

Exclusion criteria

age <16，severe tricuspid regurgitation secondary to primary pulmonary hypertension, and those with substantial missing case data.

Treatment and study plan

Huanlei Huang

Procedure

tricuspid valve replacement or plasty

Primary outcomes

  1. death rate

    Time frame: 1999-01 - 2025-01

    perioperative and longterm

  2. complications

    Time frame: 1999-01 - 2025-01

    perioperative and longterm complications

Secondary outcomes

  1. redo of tricuspid valve

    Time frame: 1999-01 - 2025-01

    redo of tricuspid valve during the follow-up

Study contacts

Contact information is provided by the study sponsor or research team.

Huanlei Huang

CONTACT

[email protected]

02083827812-10410

Yingjie Ke

CONTACT

[email protected]

02083827812-10410

Sponsors and collaborators

Lead sponsor

Guangdong Provincial People's Hospital

Other

Registry information

Official study title

Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University

Important dates

Study start
1999
Primary completion
2025
Study completion
2025
First posted
Aug 15, 2024
Registry last updated
Aug 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.